| Trial ID: | L0064 |
| Source ID: | NCT01544751
|
| Associated Drug: |
Metformin
|
| Title: |
Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin
|
| Acronym: |
--
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease (NAFLD)
|
| Interventions: |
Drug: Low dose metformin|Drug: Metformin|Drug: Atorvastatin
|
| Outcome Measures: |
Number of Participants with improvement of liver hyperechogenicity|Number of Participants with amelioration of metabolic syndrome and HOMA-Index
|
| Sponsor/Collaborators: |
Prof Antonino Belfiore|University Magna Graecia
|
| Gender: |
All
|
| Age: |
18 Years to 55 Years ?? (Adult)
|
| Phases: |
Not applicable
|
| Enrollment: |
150
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
September 2011
|
| Completion Date: |
June 2015
|
| Results First Posted: |
--
|
| Last Update Posted: |
May 28, 2014
|
| Locations: |
Endocrinology Unit, Catanzaro, Italy
|
| URL: |
https://ClinicalTrials.gov/show/NCT01544751
|
